BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Aerobiotix

1 post

Aerobiotix is a leader in air quality management solutions for healthcare, assisted living, and education. Its medical-grade items utilize ultraviolet light, HEPA filters, and special filtration to eliminate 99.9 percent of germs, viruses, VOCs, and other pollutants.

The air quality management technology is quiet, safe, and intended to operate continuously in occupied rooms to reduce the risk of infections while also enhancing environmental safety. Aerobiotix solutions include monitoring systems that help facilities around the world measure and manage air quality.

Aerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital

Biotech NewsAerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital

  • BioTech Health X
  • May 6, 2021
Aerobiotix, a pioneer in airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Relay Therapeutics (RLAY) Just Got FDA Backing—Here’s Why RLAY Stock Could Explode
  • Werewolf Therapeutics (HOWL) Can Be the Next Biotech Moonshot
  • Verastem (VSTM)’s Cancer Drug Shows 83% Response Rate — Is this the Next 10x Biotech?
  • Multikine’s 73% 5-Year Survival Rate Shocks Wall Street — Is CEL-SCI (CVM) the Next Big Winner?
  • Analysts Say Tango (TNGX) is Worth $10.43—Here’s Why It Might Go Even Higher
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • June 19, 2025
    Relay Therapeutics (RLAY) Just Got FDA Backing—Here’s Why RLAY Stock Could Explode
    • June 19, 2025
    Werewolf Therapeutics (HOWL) Can Be the Next Biotech Moonshot
    • June 19, 2025
    Verastem (VSTM)’s Cancer Drug Shows 83% Response Rate — Is this the Next 10x Biotech?
    • June 19, 2025
    Multikine’s 73% 5-Year Survival Rate Shocks Wall Street — Is CEL-SCI (CVM) the Next Big Winner?
    • June 19, 2025
    Analysts Say Tango (TNGX) is Worth $10.43—Here’s Why It Might Go Even Higher
Recent Posts
  • Is Prelude (PRLD) the Next Biotech Titan? Investors Are Watching this Stock Closely
    • June 19, 2025
  • This $1 Stock Has a $6 Price Target—Is Pyxis (PYXS) the Best Cheap Biotech Play Right Now?
    • June 19, 2025
  • Foghorn Therapeutics (FHTX) is Quietly Building a Biotech Empire—Here’s Why Investors Are Watching
    • June 19, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (195)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top